Pro Medicus's Position Has Never Been Better, Bull Says -- Market Talk
Dow Jones
Jun 03
0443 GMT - Pro Medicus has never been better positioned despite its recent share-price dive, Morgans analyst Iain Wilkie reckons. Shares in the medical-imaging tech provider shed two-thirds of their value between July and February. However, Wilkie tells clients in a note that conversations with the company and industry contacts have reinforced his view that the business is executing well from a structurally strong competitive position. With consensus forecasts now reflecting lower expectations, he keeps a buy rating and target price of 210.00 Australian dollars on the stock. Shares are up 0.3% at A$160.495. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
June 03, 2026 00:43 ET (04:43 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.